Hepatitis C New Drug Research And Liver Health
  • HCV News Of The Day
    • 2013/HCV Drugs News Digest
    • HCV Drugs: News Digest>
      • News Archive
      • Liver HCV : Specialty news digest
  • 2013 - Breaking Conference Reports/Hepatitis C
    • Breaking Conference Reports >
      • EASL 2012 Meeting Summary>
        • EASL Summary Of The 2011 March Meeting
      • AASLD- Nov 2011 Annual Meeting>
        • Conference Archive
  • Blog: New HCV Drug Updates
  • HCV FAQ
  • HCV: Newly Diagnosed?
    • Challenges-issues in managing hepatitis C
    • Ask Me A Question About Hepatitis C
  • What to do with a positive hepatitis C test
  • 2013-HCV Abstract Corner
    • HCV Abstract Corner>
      • Archive; Abstract Corner
  • 2013-Hepatitis C Full Text Articles
    • Hepatitis C Treatment Complete Studies 2012>
      • Potential new method to block the lifecycle of the Hepatitis C virus
      • Hepatitis C Treatment Complete Studies 2011
  • 2013/HCV Multimedia Videos Podcasts
    • Multimedia/Videos-Podcasts>
      • Watch How Hepatitis C Protease Inhibitors Work>
        • Multimedia; Archives Videos and Podcasts
  • 2013 Stem Cell News and Research
    • Liver-2012 Stem Cell Updates
    • Liver: 2011 Stem Cell Updates
    • What Are Stem Cells?>
      • Future applications of human stem cells
  • Recommended; Stem Cell Blogs
  • Understanding Hepatitis C
  • Natural History Of HCV
    • A 20-year cohort study on the natural history of untreated HCV infection
  • Hepatitis C Disease Progression
    • NIH scientists identify likely predictors of hepatitis C severity
    • HCV Epidemiology, Diagnosis and Disease Progression
    • Hepatitis C may increase deaths from both liver-related and other diseases>
      • Mortality in advanced HCV /long-term peginterferon
    • Host Factors on Management of HCV
  • Transmission
    • How Soon To Initiate HCV Therapy After Transmission
    • Does the Hepatitis C virus survive in dried blood ?
    • Viral Load Tied to Vertical Transmission of Hepatitis C
    • Hey Can I Get Hep C From......
    • HCV infections transmitted via a clinical setting
    • What Should I Do If I Get A Needlestick
  • How are the different types of hepatitis transmitted
    • New challenges in viral hepatitis
    • Hepatitis A virus infection in high-risk subjects
  • Your Liver Functions
  • Liver Function Tests
    • HCV-Persistently Normal (ALT) Alanine Aminotransferase Levels
    • Hey, I have a question about hcv tests and my liver
    • ALT used to separate those infected with HCV from those at low risk of liver disease
  • Lab Reports
  • HCV Viral Load Test
  • Liver Biopsy/Noninvasive Tests
    • Is there still a role for liver biopsy in managing hepatitis C virus infections?
    • Overview of Liver Biopsy Procedure
    • Three Algorithms of Non-invasive Markers of Fibrosis in Chronic Hepatitis C
    • FibroScan comparison to liver fibrosis biomarkers
  • Chronic HCV Symptoms
    • Fatigue and HCV
    • Sleep Disturbance in Chronic HCV
    • Skin Rash/Hepatitis C
    • Liver Disease: Bone Loss "It Ain't Like Menopause!"
  • HCV Neuropsychiatric symptoms-“brain fog”
    • HCV-Related Nervous System Disorders
    • Hepatitis C Virus and the Brain
    • Liver-induced inflammation hurts the brain
    • The Brain on Fire: Inflammation and Depression
  • Conditions Outside The Liver
    • Prevalence of fibromyalgia among patients with chronic hepatitis C
    • Lichen Planus and The Hepatitis C Virus
    • Dermatologic Disorders and Liver Disease
  • Chronic hepatitis C: Treat or wait?
    • Preparing For Treatment>
      • Starting Hepatitis C Treatment: Tips and Information 2011
      • Adherence To HCV Treatment-Review
      • Treating Hepatitis C; What can you do to increase your chance for SVR?
  • Hepatitis C advanced fibrosis: Treat or Wait
  • Approved Treatments for Hepatitis C
    • Adults:Treating Hepatitis C
    • Interferons and hepatitis C virus
  • HCV Treatment Failure Can Still Mean Less Liver Inflammation
  • Protease inhibitors geno-1:New standard of care
    • Treating HCV Genotype 1 In The Real World
    • 2012 - Direct acting antivirals for the treatment of chronic hepatitis C
    • HCV:End of the Beginning-Possibly-Beginning of the End
    • Patients’ Expectations About New HCV Direct-Acting Antivirals Often Unrealistic
    • What Are NS5A inhibitors ?
    • Hepatitis C Treatment Nonresponders
    • New 2011 AASLD guidelines for treating HCV
    • Treating New and Old Therapies>
      • High-grade liver inflammation may predict treatment response
  • HCV Resistance To New And Experimental Drugs
    • Understanding Resistance in Chronic HCV Infection
  • 2012 Future Prospects-Treatment of HCV
    • Advances in the treatment of hepatitis C virus infection.
  • Boceprevir & Telaprevir
    • FDA Telaprevir/Boceprevir Transcript
    • Pocket Guide Telaprevir/Boceprevir
    • Quick Facts- Direct-acting antivirals Telaprevir/Boceprevir
    • Telaprevir Or Boceprevir: What Is My Chance For A Cure?
  • 2013 News/Incivek (Telaprevir)
    • News/Telaprevir>
      • Telaprevir-IFN/ribavirin Hints at Response
      • Telaprevir FDA Approval>
        • Help-How Do I Take Incivek-telaprevir ?
        • Quick Study Of Telaprevir
        • Cost Of Treating With Telaprevir
  • 2013 News/Victrelis (Boceprevir)
    • News/ Boceprevir>
      • VICTRELIS-Boceprevir: Prescribing-Medication Guide
      • 2011;Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
      • 2011-Boceprevir for Untreated Chronic HCV Genotype 1 Infection
  • Side Effects-Interferon Free Therapies
  • Drug-Drug Interactions In Triple-Therapy
  • 2013/HCV Triple-therapy Side Effects
    • Boceprevir,Telaprevir Less Side Effects?>
      • 2013-HCV therapy geno 1: management of side-effects
      • Dry Mouth and Treatment >
        • Dry Mouth (Xerostomia)
      • Important updates to PegIntron labeling
      • Peginterferon alfa-2a Drug Interactions
      • HCV Treatment: Peginterferon and Ribavirin Side Effects
  • Genotypes/Treatment
    • Treatment Duration in Hepatitis C Virus Genotype 2/3-infected Patients
    • Impact of IL28B on Liver Histopathology in HCV Genotype 2/3
    • Genotype 3/HCV Treatment
    • HCV-Genotype 5 or 6
    • Hepatitis C-Genotype 4>
      • How to optimize HCV therapy in genotype 4 patients
      • Geno 4-Pioglitazone Decreases HCV Viral Load
    • Telaprevir/Boceprevir *genotype 1,2,3
    • (HCV) genotypes in the severity of liver disease
  • What Is The IL28B gene ?
    • Hepatitis C Test:Likelihood of achieving SVR>
      • IL28B and HCV immune responses
  • Index-Current Hepatitis C Drugs In Development
  • 2013-Interferon Free Combinations
    • Interferon-free combinations
    • 2013-Interferon free therapy w-direct acting antivirals for HCV
  • 2013 Sofosbuvir (GS-7977)
    • GS-7977-Formally PSI-7977 >
      • PSI-7977 peg/riba Geno 2/3 PROTON Trial
  • Sofosbuvir(GS7977)/Simeprevir(TMC435)
    • Interferon-Free Combo PSI-7977-TMC435
  • Sofosbuvir (GS-7977)/Ledipasvir (GS-5885)
  • GS-5885, an NS5A Inhibitor
  • ABT-450/r, ABT-267, ABT-333
  • Faldaprevir (BI 201335) and BI 207127 Interferon-Free
    • NS3/4A protease inhibitor BI201335
  • Miravirsen First MicroRNA-Targeted Drug
  • BMS-790052 (Daclatasvir)
  • Daclatasvir/VX135
  • ALS-2200 (VX-135)
  • BMS-790052/BMS-650032 Interferon-sparing
  • (TMC435) Simeprevir
  • TMC435 monotherapy in HCV genotypes 2-6
  • Simeprevir (TMC435) and TMC647055
  • Simeprevir,TMC647055 and IDX719
  • TMC435-daclatasvir-BMS-790052
  • Danoprevir-RG7227 direct-acting antiviral
  • Mericitabine- Polymerase Nuc
  • Sovaprevir (Formerly ACH-1625)
  • ACH-3102 NS5A inhibitor
  • INCIVEK, VX-222/Ribavirin
  • MK-5172 protease inhibitor
  • HCV/New Drug Pipeline
  • 2013/Hepatitis C Clinical Trials
    • Clinical Trials>
      • Learning About Clinical Trials
      • Boceprevir and Telaprevir Trials>
        • Telaprevir REALIZE STUDY
  • HCV Trials/Discontinued Or On Hold
    • Idenix IDX184-Hepatitis C drug
    • TMC435-BMS-986094-formerly INX-189
  • Women's Health; Treating Hepatitis C
    • Early Menopause and Response to HCV Treatment
  • Hepatitis C in Pregnancy
  • Treating Hepatitis C In Children
    • 2012 Hepatitis C infection in children
    • Autoimmunity/Extrahepatic Manifestations in HCV Treatment-Naïve Children
    • Study-long-term safety/durability of virologic response in paediatric patients who were previously treated w-interferon alfa-2b plus ribavirin for 48 weeks
  • Liver Disease in Elderly Patients
  • Dental considerations in patients with liver disease
    • HCV: Dental management-Diagnosis of extrahepatic manifestations>
      • Dental problems delaying the initiation of interferon
  • Fibrosis
    • Is there a natural way to improve liver fibrosis ?
  • 2013 News/Fibrosis
    • News: Fibrosis
  • Cirrhosis
    • What Is Cirrhosis ?
    • Advanced Liver Disease: What Every HCV Treater Should Know
    • The Patient With Cirrhosis: Don't Miss This
    • Hey, I have a question about cirrhosis
    • Physical Findings Suggestive Of Cirrhosis/Photos
    • Staging Cirrhosis>
      • When the Spleen Gets Tough, the Varices Get Going
    • Management Cirrhosis: How Are We Doing?
    • Cirrhosis Regression
    • Cirrhosis ; Surgery in the Patient with Liver Disease
    • Hepatic Encephalopathy>
      • Varices
      • Ascites
      • Management of ascites
  • 2013 News/Cirrhosis
    • News: Cirrhosis>
      • GI Bleeds: Withholding Transfusions Boosts Survival
  • Liver Transplant
    • New HCV Drugs:Expected Risks-Challenges in Liver Transplant
    • Prevention of hepatitis C recurrence after liver transplantation>
      • Effects of Telaprevir on Cyclosporine and Tacrolimus Pharmacokinetics Make Utility in Post-OLT Setting Uncertain
      • HCV Treatment After Liver Transplant
      • Antivirals Ineffective Against HCV After LT
  • 2013 News/Transplant
    • Liver Transplant News
  • Hepatocellular Carcinoma
    • Audio:Liver Cancer
    • Radioembolisation (RE),Selective Internal Radiation Therapy (SIRT)
    • Diagnosis (markers) of early hepatocellular carcinoma
    • Intrahepatic cholangiocarcinoma
    • Treatment TheraSphere/HCC/primary liver cancer
    • Liver Cancer : Microwave Ablation (MWA)
    • Pain May Predict Liver Cancer Prognosis
    • What Is the Indication for Sorafenib in Hepatocellular Carcinoma?
    • Liver Cysts and Tumors"Two Totally Different Concepts"
    • Interactive map of cancer mortality risk worldwide
  • 2013 News/Liver Cancer
    • Liver Cancer News and Updates
    • Vitamin E may lower liver cancer risk
  • Guidelines Nonalcoholic Fatty Liver Disease (NAFLD)
    • Fatty Liver And HCV>
      • Touching some firm ground in the epidemiology of NASH
      • Ultrasound/Liver Biopsy
      • Fatty Liver and Treatment
      • Liver fibrosis/Fatty Liver
  • 2013-Coffee and Liver Disease
  • Liver Regeneration
  • Liver Health
    • Choline: Great for the Liver
    • Medications for sleep in liver disease
    • The odds of gallbladder disease in Hepatitis C Patients
    • HCV & Gallbladder Disease:
    • Enlarged Spleen
    • HCV And Cardiovascular Risk
  • Nutrition-Herbs-Vitamins
    • Vitamin D and Treatment
    • Liver Disease - The Mediterranean Diet
    • Diet: Cirrhosis>
      • Low-Salt Diet-A Must in Cirrhosis
      • Diet for Liver Disease Low Sodium and More
      • Vitamin B12 supplements may help treat hepatitis
      • Nutrition in end-stage liver disease
      • Cirrhosis; Vitamin K Deficiencies
      • Vitamin D Levels In Cirrhosis
      • Vitamin D could de-stress Liver Disease Treatments
      • Drugs And Cirrhosis
      • Cancer and Berries
  • 2013-Silymarin for HCV infection
  • Milk Thistle
    • 2012-Milk Thistle No Help in Tough Hepatitis C Cases
    • Silymarin-Milk Thistle for NAFLD
    • Milk thistle"- Silibinin in hepatitis C related liver transplantation
    • Milk Thistle is coming to America
    • Caution! Herbs and Nutritional Supplements
  • HCV Drugs: Financial Support
  • HCV Filing For Social Security
  • Hepatitis C: A Rational Call To Arms
    • Hepatitis C; A Forced Legacy
    • Outsourcing:Globalization of the pharmaceutical industry>
      • Inspirational
  • Hepatitis C Links / Best On The Web
    • Chat and Message Boards
  • Whose Website Is This ?
  • Feedback/Contact Us

Preparing For Treatment

Picture

Video/Feb 2013- Getting Ready for Hepatitis C Treatment


Preparing You and Your Family Before You Start Treatment
By Kathy Jensen, LCSW

You’ve been doing your homework, getting medical opinions, reading everything you can find, attending support groups and have made your decision: I’m going to do treatment!

Along with preparing physically, spiritually, and financially, how have you prepared your kids (or grandkids, or nieces and nephews?)
How can you ensure that they also understand and support you?
Here are some tips.

Be honest. Children and adolescents need different approaches based on their age, maturity, and coping abilities, but they all need to know what is happening. If you don’t share openly, they can still sense that something is up, and usually they imagine the worst. Trying to “spare” them any pain can often backfire.

Give them facts appropriate for their age. It is common for children to believe that they somehow caused your illness or have made it worse through something they did or secretly wished in their own moments of anger or frustration. If you have never discussed your diagnosis with them, this is the time to give them some information.

Tell them enough but not more than they need. Find language that they can understand. I once heard someone explain a healthy liver as a “brand new sponge, that is soft and easily soaks up water. As the liver has scarring, the sponge feels hard and doesn’t work as well as it did when it was new. The medicine I am going to take will help my liver be soft and smooth again.” Be positive and hopeful.

Listen carefully. What are their questions? They can be as awesome as “Are you going to die?” to “Does this mean I can’t go to Danny’s birthday party next week?”

Reassure them that they are loved and will always be taken care of, and that you will keep them informed. “Mommy is strong, and we are doing everything possible to cure the disease.”

Tell them about the treatment and how you might be feeling from side effects. Encourage a discussion about how they might be able to help you, such as little (or big, depending on their age) chores they can take on. Stress that this will not last forever but may last 6 months to a year. For younger kids, putting together a box of quiet activities they can enjoy while you are resting can be a way to have them involved in your planning.

Watch and see how they handle it. Adolescents can sometimes have a very hard time with a parent’s illness. They are trying to move away from you, and now you may have to depend on them. This can create some challenges. Try to keep the communication open. Don’t be afraid to share your feelings with a teen: “This really makes me angry, sad, and scared too, but I know we can get through it okay.”

Signs that your child is not coping well, include: (symptoms lasting more than a few weeks)

Marked change in personality and mood
Decreased appetite
Acting out at home or school
Withdrawal from you, friends or normal activities
Physical complaints like headaches and stomachaches
If you are concerned, talk to your child’s doctor, teacher, school counselor, etc. .

How do I establish family and social support?

Hearing for the first time that you have been diagnosed with hepatitis C
can be a very difficult and frightening experience, not only for yourself,
but also for others who play an important role in your life. It may be
helpful for you to discuss your diagnosis with those who are close to you.
Should you decide to talk to your family or other people close to you
about your diagnosis with hepatitis C, it may not be easy. But once they
know, they may be able to provide you with the help and support you
need to manage your illness in the best way possible.

You may want to:

◆ Explain what hepatitis C is and how it is spread.
◆ Talk about ways you can help protect them and how they can
protect themselves from getting hepatitis C.
◆ Share information with your children that is appropriate for their
age. Give them only the information they need.
◆ Have a friend or family member go with you to your medical
appointments.

OTHER HELPFUL INFORMATION

How do I cope with my feelings?

Being diagnosed with an illness like hepatitis C can be an overwhelming
experience. You may feel scared, sad, angry, tired, or even empty inside.
You may lose interest in things that are important to you. These feelings
are quite common, and can fade with time, treatment, and support from
others. When these feelings do not go away, become stronger, or keep
you from doing your daily activities, you may be experiencing signs of
a more serious condition called depression. Try talking about your sad
and angry feelings to your family members and friends. And let your
health care provider know about these feelings so that you get the help
you may need.

ASKING THE RIGHT QUESTIONS

These questions may help you communicate with your
health care providers and manage your illness. Some questions may not
apply to your specific situation, or some questions may be appropriate
to ask at a later time. These questions are not a complete list, and are
meant only to guide you in your discussions with your providers. You
may find it helpful to take this booklet with you to your appointment
and record answers to the questions you ask.

Questions About a Health Care Provider’s

Experience with Hepatitis C:
◆ Do you have many other patients with hepatitis C?
◆ Do you feel up-to-date on all the latest changes and advancements
in hepatitis C treatment?
◆ Do you think I should be referred to a liver specialist for my care?
Questions About Testing:
The following questions relate to routine and one-time liver tests:
◆ What is my hepatitis C viral load?
– (If you have already gotten a viral load test)

What are the test results?
– How often should I have my viral load checked?
– May I have a copy of the test results for my records?

What is my hepatitis C genotype?

(This is a one-time liver test)
– (If you have already gotten a genotype test) What are the test results?
– How does my genotype affect my illness and possible treatment?
– May I have a copy of the test results for my records?

◆ What are my liver function test levels?

(Liver function tests are ALT/
AST,ALP, and SGTP, bilirubin, albumin, and prothrombin time)
– (If you have already gotten liver function tests)

What are the test results?

How do they compare with normal levels?
– How often should I have liver function tests done?
– May I have a copy of the test results for my records?

◆ Do you recommend I have a liver biopsy?
– If yes, why? If no, why not?
– What is involved in getting a biopsy?
• What are the risks?
• How is the procedure performed?
• How long does the procedure take?

– What experience do you have, or does the doctor performing the
procedure have in doing liver biopsies?
(The more experience they have, the better.)

– If a liver biopsy shows that I have fibrosis or cirrhosis (scarring),
how does that affect my treatment options?

– (If you have already gotten a biopsy)

What are the results of my liver biopsy and what does it mean?

Will the result affect my treatment?

– May I have a copy of the biopsy report for my records?

May 2012-
Noninvasive Methods to Assess Liver Disease in Patients With
Hepatitis B or C

The prognosis and management of patients with chronic viral hepatitis B and C
depend on the amount and progression of liver fibrosis and the risk for
cirrhosis. Liver biopsy, traditionally considered to be the reference standard
for staging of fibrosis, has been challenged over the past decade by the
development of noninvasive methodologies. These methods rely on distinct but
complementary approaches: a biologic approach, which quantifies serum levels of
biomarkers of fibrosis, and a physical approach, which measures liver stiffness
by ultrasound or magnetic resonance elastography. Noninvasive methods were
initially studied and validated in patients with chronic hepatitis C but are now
used increasingly for patients with hepatitis B, reducing the need for liver
biopsy analysis. We review the advantages and limitations of the noninvasive
methods used to manage patients with chronic viral hepatitis B or C infection.

Questions About Medical Treatment

(if you are on treatment or thinking about treatment)

◆ Do you feel I am a good candidate for the newer FDA approved Oral Inhibitors
such as Telaprevir or Boceprevir

These two drugs- Telaprevir/INCIVEK and Boceprevir/Vicrelis will be used in combination
with pegylated interferon/Ribavirin in people with genotype 1. 
 

If not what are my opitions for treatment?
Should I wait until newer drugs for hepatitis C are FDA approved?

Whould this increase my chances for a cure ?

– If so, why?
– If not, why?

– What will happen if I decide to wait to start treatment?

◆ What are the pros and cons of beginning treatment?
– What are the potential side effects of the interferon and ribavirin,
pegylated interferon or when adding the new oral inhibitors ?

How long do you think I will have to be on therapy?
– How is the treatment taken?
– How may the treatment affect my life and my lifestyle?
– What is the likelihood that the treatment will be successful?
– Do I have to change how or when I eat if I choose to be treated?
– Should my partner or I take birth control pills while on the
medications?
– Can my partner (or I) get pregnant safely while I am on the
medications?

◆ If I have a history of mental health issues (depression/anxiety), will I
be a candidate for hepatitis C treatment?
– How will my mental health be managed?
– What will be done if my mental health gets worse?

Hepatitis C Self Care:

◆ How does my diet affect the hepatitis C virus?
– Do I have to change how and when I eat now that I have hepatitis C?
– May I be referred to a dietitian or nutritionist for help with my
dietary needs?
◆ How do my social habits (drinking alcohol, using drugs, smoking)
affect my liver or the hepatitis C virus?
◆ Do I need to stop drinking alcohol completely?
◆ If I want to stop using alcohol and/or other drugs, can you refer me
to an alcohol and drug counselor?
◆ If I want to stop smoking, can you refer me to someone to help me quit?
◆ Do I have to change my sexual practices? Should my partner(s) and
children be tested?
◆ What kinds of symptoms/signs can I expect now that I have been
diagnosed with hepatitis C?
◆ What if I feel fine? Does that mean my liver is not damaged?
◆ Do you recommend that I have tests done to see about the condition
of my liver? If yes, which tests?
◆ Do you recommend that I begin treatment for hepatitis C? If yes,
which treatment do you recommend and why?
◆ Is there a support group in the area that I can attend?

Other Infections:

◆ Do I need to be tested to see if I am immune to hepatitis A and/or
hepatitis B?
◆ Am I immune to hepatitis A and/or hepatitis B? If not, do you
recommend I be vaccinated for either or both hepatitis A and B viruses?
◆ Should I be tested for HIV or other infections?

Questions About Follow-Up Care:

◆ How often should I return for follow-up?
◆ Can I schedule an appointment now?
◆ What should I do if my health gets worse between now and the next
time I see you?
– Can I call your office and make an earlier appointment?
◆ Are you available by phone and/or email?

Helpful LInks
2013
Chronic  Hepatitis C  Infection: Treat Now or Wait?

2008
Information From HCV Advocate : A Guide For Preparing For HCV Treatment

Source - http://hepc-connection.org/Documents/LivingWithHEPCBooklet2010.pdf

Page updated Feb 2013


Copyright 2010-2013 Hepatitis C New Drug Research And Liver Health